|
CNOT6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.576600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.835700E-02 |
| Normal-vs-Stage2 |
7.108100E-02 |
| Normal-vs-Stage3 |
5.807800E-04 |
| Normal-vs-Stage4 |
6.45919999999744E-05 |
| Stage1-vs-Stage2 |
5.100400E-01 |
| Stage1-vs-Stage3 |
4.249800E-02 |
| Stage1-vs-Stage4 |
7.116600E-03 |
| Stage2-vs-Stage3 |
4.500800E-01 |
| Stage2-vs-Stage4 |
2.559800E-01 |
| Stage3-vs-Stage4 |
5.945400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.462580E-03 |
| Normal-vs-AfricanAmerican |
1.301500E-03 |
| Normal-vs-Asian |
6.257400E-01 |
| Caucasian-vs-AfricanAmerican |
2.768000E-01 |
| Caucasian-vs-Asian |
2.244800E-01 |
| AfricanAmerican-vs-Asian |
7.382100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.594400E-04 |
| Normal-vs-Female |
4.834500E-02 |
| Male-vs-Female |
9.486400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.031560E-01 |
| Normal-vs-Age(41-60Yrs) |
4.095700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.388570E-04 |
| Normal-vs-Age(81-100Yrs) |
1.368470E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.876600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.505200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.118800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.052500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.293600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.771200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.237000E-01 |
| Normal-vs-Grade 2 |
1.467400E-01 |
| Normal-vs-Grade 3 |
3.607100E-04 |
| Normal-vs-Grade 4 |
3.19800000003756E-06 |
| Grade 1-vs-Grade 2 |
2.417200E-01 |
| Grade 1-vs-Grade 3 |
3.978400E-02 |
| Grade 1-vs-Grade 4 |
4.517800E-03 |
| Grade 2-vs-Grade 3 |
1.831580E-02 |
| Grade 2-vs-Grade 4 |
7.608300E-04 |
| Grade 3-vs-Grade 4 |
1.135200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.762800E-01 |
| Normal-vs-ccB subtype |
1.359290E-04 |
| ccA subtype-vs-ccB subtype |
7.767700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.115500E-03 |
| Normal-vs-N1 |
1.543350E-01 |
| N0-vs-N1 |
6.424800E-01 |
|
|
